Revenue: The sum of all revenue fields included for a company's operating activities.
Tibet Pharmaceuticals Inc. (TBET) had Revenue of $8.58M for the most recently reported fiscal quarter, ending 2011-09-30.
| Income Statement Financials | |
|
Revenue |
$8.58M |
$1.65M |
|
$5.63M |
|
$2.95M |
|
$6.96M |
|
$1.62M |
|
$0.03M |
|
$1.64M |
|
$1.64M |
|
$1.64M |
|
$1.65M |
|
$1.65M |
|
$1.64M |
|
$1.62M |
|
$2.00M |
|
14.85M |
|
14.85M |
|
$0.11 |
|
$0.11 |
|
| Balance Sheet Financials | |
$43.74M |
|
-- |
|
$0.47M |
|
$50.22M |
|
$3.02M |
|
-- |
|
-- |
|
$3.02M |
|
$47.19M |
|
$46.73M |
|
$47.20M |
|
-- |
|
| Cash Flow Statement Financials | |
$3.26M |
|
$0.00M |
|
$14.42M |
|
$7.57M |
|
$25.95M |
|
$18.38M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
34.25% |
|
18.91% |
|
18.91% |
|
-- |
|
19.11% |
|
19.18% |
|
$3.26M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
3.24 |
|
0.68 |
|
132.96 |
|
3.49% |
|
3.52% |
|
3.28% |
|
3.49% |
|
-- |
|
$0.22 |
|
$0.22 |
|